Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 167 entries
Sorted by: Best Match Show Resources per page
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Nature communications

Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC.
PMID: 33990587
Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4.

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.

Cite
Coignard J, Lush M, Beesley J, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021;12(1):2986doi: 10.1038/s41467-021-23162-4.
Coignard, J., Lush, M., Beesley, J., O'Mara, T. A., Dennis, J., Tyrer, J. P., Barnes, D. R., McGuffog, L., Leslie, G., Bolla, M. K., Adank, M. A., Agata, S., Ahearn, T., Aittomäki, K., Andrulis, I. L., Anton-Culver, H., Arndt, V., Arnold, N., Aronson, K. J., Arun, B. K., Augustinsson, A., Azzollini, J., Barrowdale, D., Baynes, C., Becher, H., Bermisheva, M., Bernstein, L., Białkowska, K., Blomqvist, C., Bojesen, S. E., Bonanni, B., Borg, A., Brauch, H., Brenner, H., Burwinkel, B., Buys, S. S., Caldés, T., Caligo, M. A., Campa, D., Carter, B. D., Castelao, J. E., Chang-Claude, J., Chanock, S. J., Chung, W. K., Claes, K. B. M., Clarke, C. L., Collée, J. M., Conroy, D. M., Czene, K., Daly, M. B., Devilee, P., Diez, O., Ding, Y. C., Domchek, S. M., Dörk, T., Dos-Santos-Silva, I., Dunning, A. M., Dwek, M., Eccles, D. M., Eliassen, A. H., Engel, C., Eriksson, M., Evans, D. G., Fasching, P. A., Flyger, H., Fostira, F., Friedman, E., Fritschi, L., Frost, D., Gago-Dominguez, M., Gapstur, S. M., Garber, J., Garcia-Barberan, V., García-Closas, M., García-Sáenz, J. A., Gaudet, M. M., Gayther, S. A., Gehrig, A., Georgoulias, V., Giles, G. G., Godwin, A. K., Goldberg, M. S., Goldgar, D. E., González-Neira, A., Greene, M. H., Guénel, P., Haeberle, L., Hahnen, E., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Harrington, P. A., Hart, S. N., He, W., Hogervorst, F. B. L., Hollestelle, A., Hopper, J. L., Horcasitas, D. J., Hulick, P. J., Hunter, D. J., Imyanitov, E. N., Jager, A., Jakubowska, A., James, P. A., Jensen, U. B., John, E. M., Jones, M. E., Kaaks, R., Kapoor, P. M., Karlan, B. Y., Keeman, R., Khusnutdinova, E., Kiiski, J. I., Ko, Y. D., Kosma, V. M., Kraft, P., Kurian, A. W., Laitman, Y., Lambrechts, D., Le Marchand, L., Lester, J., Lesueur, F., Lindstrom, T., Lopez-Fernández, A., Loud, J. T., Luccarini, C., Mannermaa, A., Manoukian, S., Margolin, S., Martens, J. W. M., Mebirouk, N., Meindl, A., Miller, A., Milne, R. L., Montagna, M., Nathanson, K. L., Neuhausen, S. L., Nevanlinna, H., Nielsen, F. C., O'Brien, K. M., Olopade, O. I., Olson, J. E., Olsson, H., Osorio, A., Ottini, L., Park-Simon, T. W., Parsons, M. T., Pedersen, I. S., Peshkin, B., Peterlongo, P., Peto, J., Pharoah, P. D. P., Phillips, K. A., Polley, E. C., Poppe, B., Presneau, N., Pujana, M. A., Punie, K., Radice, P., Rantala, J., Rashid, M. U., Rennert, G., Rennert, H. S., Robson, M., Romero, A., Rossing, M., Saloustros, E., Sandler, D. P., Santella, R., Scheuner, M. T., Schmidt, M. K., Schmidt, G., Scott, C., Sharma, P., Soucy, P., Southey, M. C., Spinelli, J. J., Steinsnyder, Z., Stone, J., Stoppa-Lyonnet, D., Swerdlow, A., Tamimi, R. M., Tapper, W. J., Taylor, J. A., Terry, M. B., Teulé, A., Thull, D. L., Tischkowitz, M., Toland, A. E., Torres, D., Trainer, A. H., Truong, T., Tung, N., Vachon, C. M., Vega, A., Vijai, J., Wang, Q., Wappenschmidt, B., Weinberg, C. R., Weitzel, J. N., Wendt, C., Wolk, A., Yadav, S., Yang, X. R., Yannoukakos, D., Zheng, W., Ziogas, A., Zorn, K. K., Park, S. K., Thomassen, M., Offit, K., Schmutzler, R. K., Couch, F. J., Simard, J., Chenevix-Trench, G., Easton, D. F., Andrieu, N., & Antoniou, A. C. (2021). Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature communications, 12(1), 2986. https://doi.org/10.1038/s41467-021-23162-4
Coignard, Juliette, et al. "Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers." Nature communications vol. 12,1 (2021): 2986. doi: https://doi.org/10.1038/s41467-021-23162-4
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4. PMID: 33990587; PMCID: PMC8121813.
Copy Download .nbib Format: NLM
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer.

Cancers

Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP, Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A.
PMID: 34071842
Cancers (Basel). 2021 May 27;13(11). doi: 10.3390/cancers13112627.

BACKGROUND: To develop an international, multi-site nomogram for side-specific prediction of extraprostatic extension (EPE) of prostate cancer based on clinical, biopsy, and magnetic resonance imaging- (MRI) derived data.METHODS: Ten institutions from the USA and Europe contributed clinical and side-specific...

Cite
Wibmer AG, Kattan MW, Alessandrino F, et al. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers (Basel). 2021;13(11)doi: 10.3390/cancers13112627.
Wibmer, A. G., Kattan, M. W., Alessandrino, F., Baur, A. D. J., Boesen, L., Franco, F. B., Bonekamp, D., Campa, R., Cash, H., Catalá, V., Crouzet, S., Dinnoo, S., Eastham, J., Fennessy, F. M., Ghabili, K., Hohenfellner, M., Levi, A. W., Ji, X., Løgager, V., Margolis, D. J., Moldovan, P. C., Panebianco, V., Penzkofer, T., Puech, P., Radtke, J. P., Rouvière, O., Schlemmer, H. P., Sprenkle, P. C., Tempany, C. M., Vilanova, J. C., Weinreb, J., Hricak, H., & Shukla-Dave, A. (2021). International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers, 13(11), . https://doi.org/10.3390/cancers13112627
Wibmer, Andreas G, et al. "International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer." Cancers vol. 13,11 (2021). doi: https://doi.org/10.3390/cancers13112627
Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP, Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers (Basel). 2021 May 27;13(11). doi: 10.3390/cancers13112627. PMID: 34071842; PMCID: PMC8198352.
Copy Download .nbib Format: NLM
Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies.

European journal of preventive cardiology

Hansen KW, Peytz N, Blokstra A, Bojesen SE, Celis-Morales C, Chrysohoou C, Clays E, De Bacquer D, Galatius S, Gray SR, Ho F, Kavousi M, Koolhaas CM, Kouvari M, Løchen ML, Marques-Vidal P, Osler M, Panagiotakos D, Pell JP, Sulo G, Tell GS, Vassiliou V, Verschuren WMM, Prescott E.
PMID: 33564885
Eur J Prev Cardiol. 2021 Dec 20;28(14):1590-1598. doi: 10.1093/eurjpc/zwaa146.

AIMS: To assess the association between past level of physical activity (PA) and risk for death during the acute phase of myocardial infarction (MI) in a pooled analysis of cohort studies.METHODS AND RESULTS: European cohorts including participants with a...

Cite
Hansen KW, Peytz N, Blokstra A, et al. Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. Eur J Prev Cardiol. 2021;28(14):1590-1598doi: 10.1093/eurjpc/zwaa146.
Hansen, K. W., Peytz, N., Blokstra, A., Bojesen, S. E., Celis-Morales, C., Chrysohoou, C., Clays, E., De Bacquer, D., Galatius, S., Gray, S. R., Ho, F., Kavousi, M., Koolhaas, C. M., Kouvari, M., Løchen, M. L., Marques-Vidal, P., Osler, M., Panagiotakos, D., Pell, J. P., Sulo, G., Tell, G. S., Vassiliou, V., Verschuren, W. M. M., & Prescott, E. (2021). Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. European journal of preventive cardiology, 28(14), 1590-1598. https://doi.org/10.1093/eurjpc/zwaa146
Hansen, Kim Wadt, et al. "Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies." European journal of preventive cardiology vol. 28,14 (2021): 1590-1598. doi: https://doi.org/10.1093/eurjpc/zwaa146
Hansen KW, Peytz N, Blokstra A, Bojesen SE, Celis-Morales C, Chrysohoou C, Clays E, De Bacquer D, Galatius S, Gray SR, Ho F, Kavousi M, Koolhaas CM, Kouvari M, Løchen ML, Marques-Vidal P, Osler M, Panagiotakos D, Pell JP, Sulo G, Tell GS, Vassiliou V, Verschuren WMM, Prescott E. Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. Eur J Prev Cardiol. 2021 Dec 20;28(14):1590-1598. doi: 10.1093/eurjpc/zwaa146. PMID: 33564885.
Copy Download .nbib Format: NLM
HER3 Is an Actionable Target in Advanced Prostate Cancer.

Cancer research

Gil V, Miranda S, Riisnaes R, Gurel B, D'Ambrosio M, Vasciaveo A, Crespo M, Ferreira A, Brina D, Troiani M, Sharp A, Sheehan B, Christova R, Seed G, Figueiredo I, Lambros M, Dolling D, Rekowski J, Alajati A, Clarke M, Pereira R, Flohr P, Fowler G, Boysen G, Sumanasuriya S, Bianchini D, Rescigno P, Aversa C, Tunariu N, Guo C, Paschalis A, Bertan C, Buroni L, Ning J, Carreira S, Workman P, Swain A, Califano A, Shen MM, Alimonti A, Neeb A, Welti J, Yuan W, de Bono J.
PMID: 34753775
Cancer Res. 2021 Dec 15;81(24):6207-6218. doi: 10.1158/0008-5472.CAN-21-3360. Epub 2021 Nov 09.

It has been recognized for decades that ERBB signaling is important in prostate cancer, but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically. However, we show here that membranous HER3 protein is commonly...

Cite
Gil V, Miranda S, Riisnaes R, et al. HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer Res. 2021;81(24):6207-6218doi: 10.1158/0008-5472.CAN-21-3360.
Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D'Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., Sharp, A., Sheehan, B., Christova, R., Seed, G., Figueiredo, I., Lambros, M., Dolling, D., Rekowski, J., Alajati, A., Clarke, M., Pereira, R., Flohr, P., Fowler, G., Boysen, G., Sumanasuriya, S., Bianchini, D., Rescigno, P., Aversa, C., Tunariu, N., Guo, C., Paschalis, A., Bertan, C., Buroni, L., Ning, J., Carreira, S., Workman, P., Swain, A., Califano, A., Shen, M. M., Alimonti, A., Neeb, A., Welti, J., Yuan, W., de Bono, J. (2021). HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer research, 81(24), 6207-6218. https://doi.org/10.1158/0008-5472.CAN-21-3360
Gil, Veronica, et al. "HER3 Is an Actionable Target in Advanced Prostate Cancer." Cancer research vol. 81,24 (2021): 6207-6218. doi: https://doi.org/10.1158/0008-5472.CAN-21-3360
Gil V, Miranda S, Riisnaes R, Gurel B, D'Ambrosio M, Vasciaveo A, Crespo M, Ferreira A, Brina D, Troiani M, Sharp A, Sheehan B, Christova R, Seed G, Figueiredo I, Lambros M, Dolling D, Rekowski J, Alajati A, Clarke M, Pereira R, Flohr P, Fowler G, Boysen G, Sumanasuriya S, Bianchini D, Rescigno P, Aversa C, Tunariu N, Guo C, Paschalis A, Bertan C, Buroni L, Ning J, Carreira S, Workman P, Swain A, Califano A, Shen MM, Alimonti A, Neeb A, Welti J, Yuan W, de Bono J. HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer Res. 2021 Dec 15;81(24):6207-6218. doi: 10.1158/0008-5472.CAN-21-3360. Epub 2021 Nov 09. PMID: 34753775.
Copy Download .nbib Format: NLM
Childhood ADHD and treatment outcome: the role of maternal functioning.

Child and adolescent psychiatry and mental health

Rasmussen PD, Storebø OJ, Shmueli-Goetz Y, Bojesen AB, Simonsen E, Bilenberg N.
PMID: 29983736
Child Adolesc Psychiatry Ment Health. 2018 Jun 14;12:31. doi: 10.1186/s13034-018-0234-3. eCollection 2018.

BACKGROUND: Relatively little is known about the role of maternal functioning in terms of attention deficit hyperactivity disorder (ADHD) symptoms, attachment style and resilience as predictive factors for treatment outcome when offspring are diagnosed with ADHD.OBJECTIVE: To investigate whether...

Cite
Rasmussen PD, Storebø OJ, Shmueli-Goetz Y, et al. Childhood ADHD and treatment outcome: the role of maternal functioning. Child Adolesc Psychiatry Ment Health. 2018;12:31doi: 10.1186/s13034-018-0234-3.
Rasmussen, P. D., Storebø, O. J., Shmueli-Goetz, Y., Bojesen, A. B., Simonsen, E., & Bilenberg, N. (2018). Childhood ADHD and treatment outcome: the role of maternal functioning. Child and adolescent psychiatry and mental health, 1231. https://doi.org/10.1186/s13034-018-0234-3
Rasmussen, Pernille Darling, et al. "Childhood ADHD and treatment outcome: the role of maternal functioning." Child and adolescent psychiatry and mental health vol. 12 (2018): 31. doi: https://doi.org/10.1186/s13034-018-0234-3
Rasmussen PD, Storebø OJ, Shmueli-Goetz Y, Bojesen AB, Simonsen E, Bilenberg N. Childhood ADHD and treatment outcome: the role of maternal functioning. Child Adolesc Psychiatry Ment Health. 2018 Jun 14;12:31. doi: 10.1186/s13034-018-0234-3. eCollection 2018. PMID: 29983736; PMCID: PMC6003115.
Copy Download .nbib Format: NLM
Loss-of-function polymorphism in .

EClinicalMedicine

Pedersen KM, Çolak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG.
PMID: 32382712
EClinicalMedicine. 2020 Feb 19;21:100280. doi: 10.1016/j.eclinm.2020.100280. eCollection 2020 Apr.

BACKGROUND: Whether inflammation is independently associated with development of METHODS: We genotyped 107,969 Danes from the Copenhagen General Population Study for the FINDINGS: 36,871 were non-carriers, 52,500 heterozygotes, and 18,598 homozygotes for the T-allele of the INTERPRETATION: A loss-of-function...

Cite
Pedersen KM, Çolak Y, Ellervik C, et al. Loss-of-function polymorphism in . EClinicalMedicine. 2020;21:100280doi: 10.1016/j.eclinm.2020.100280.
Pedersen, K. M., Çolak, Y., Ellervik, C., Hasselbalch, H. C., Bojesen, S. E., & Nordestgaard, B. G. (2020). Loss-of-function polymorphism in . EClinicalMedicine, 21100280. https://doi.org/10.1016/j.eclinm.2020.100280
Pedersen, Kasper Mønsted, et al. "Loss-of-function polymorphism in ." EClinicalMedicine vol. 21 (2020): 100280. doi: https://doi.org/10.1016/j.eclinm.2020.100280
Pedersen KM, Çolak Y, Ellervik C, Hasselbalch HC, Bojesen SE, Nordestgaard BG. Loss-of-function polymorphism in . EClinicalMedicine. 2020 Feb 19;21:100280. doi: 10.1016/j.eclinm.2020.100280. eCollection 2020 Apr. PMID: 32382712; PMCID: PMC7201035.
Copy Download .nbib Format: NLM
Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1.

Protein expression and purification

Rafiq M, Ernst HA, Aduri NG, Prabhala BK, Tufail S, Rahman M, Bloch MB, Mirza N, Taylor NMI, Boesen T, Gajhede M, Mirza O.
PMID: 34637915
Protein Expr Purif. 2022 Feb;190:105990. doi: 10.1016/j.pep.2021.105990. Epub 2021 Oct 09.

The human peptide transporter hPEPT1 (SLC15A1) is responsible for uptake of dietary di- and tripeptides and a number of drugs from the small intestine by utilizing the proton electrochemical gradient, and hence an important target for peptide-like drug design...

Cite
Rafiq M, Ernst HA, Aduri NG, et al. Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1. Protein Expr Purif. 2021;190:105990doi: 10.1016/j.pep.2021.105990.
Rafiq, M., Ernst, H. A., Aduri, N. G., Prabhala, B. K., Tufail, S., Rahman, M., Bloch, M. B., Mirza, N., Taylor, N. M. I., Boesen, T., Gajhede, M., & Mirza, O. (2022). Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1. Protein expression and purification, 190105990. https://doi.org/10.1016/j.pep.2021.105990
Rafiq, Maria, et al. "Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1." Protein expression and purification vol. 190 (2022): 105990. doi: https://doi.org/10.1016/j.pep.2021.105990
Rafiq M, Ernst HA, Aduri NG, Prabhala BK, Tufail S, Rahman M, Bloch MB, Mirza N, Taylor NMI, Boesen T, Gajhede M, Mirza O. Expression, purification and characterization of human proton-coupled oligopeptide transporter 1 hPEPT1. Protein Expr Purif. 2022 Feb;190:105990. doi: 10.1016/j.pep.2021.105990. Epub 2021 Oct 09. PMID: 34637915.
Copy Download .nbib Format: NLM
Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering.

Rheumatology (Oxford, England)

Wetterslev M, Georgiadis S, Juul Sørensen I, Juhl Pedersen S, Christiansen SN, Hetland ML, Brahe CH, Bakkegaard M, Duer A, Boesen M, Gosvig KK, Møller JM, Krogh NS, Jensen B, Madsen OR, Christensen J, Hansen A, Nørregaard J, Røgind H, Østergaard M.
PMID: 34636846
Rheumatology (Oxford). 2021 Oct 12; doi: 10.1093/rheumatology/keab755. Epub 2021 Oct 12.

OBJECTIVES: In a 2-year follow-up study of patients with axial spondyloarthritis (axSpA) in clinical remission who tapered tumor necrosis factor inhibitor (TNFi) treatment according to a clinical guideline, we aimed to investigate the proportion who successfully tapered/discontinued therapy and...

Cite
Wetterslev M, Georgiadis S, Juul Sørensen I, et al. Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering. Rheumatology (Oxford). 2021;doi: 10.1093/rheumatology/keab755.
Wetterslev, M., Georgiadis, S., Juul Sørensen, I., Juhl Pedersen, S., Christiansen, S. N., Hetland, M. L., Brahe, C. H., Bakkegaard, M., Duer, A., Boesen, M., Gosvig, K. K., Møller, J. M., Krogh, N. S., Jensen, B., Madsen, O. R., Christensen, J., Hansen, A., Nørregaard, J., Røgind, H., & Østergaard, M. (2021). Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/keab755
Wetterslev, Marie, et al. "Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering." Rheumatology (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/rheumatology/keab755
Wetterslev M, Georgiadis S, Juul Sørensen I, Juhl Pedersen S, Christiansen SN, Hetland ML, Brahe CH, Bakkegaard M, Duer A, Boesen M, Gosvig KK, Møller JM, Krogh NS, Jensen B, Madsen OR, Christensen J, Hansen A, Nørregaard J, Røgind H, Østergaard M. Tapering of TNF inhibitors in axial spondyloarthritis in routine care-2-year clinical and MRI outcomes and predictors of successful tapering. Rheumatology (Oxford). 2021 Oct 12; doi: 10.1093/rheumatology/keab755. Epub 2021 Oct 12. PMID: 34636846.
Copy Download .nbib Format: NLM
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents.

Journal of clinical epidemiology

Boesen K, Jørgensen KJ, Gøtzsche PC.
PMID: 34752938
J Clin Epidemiol. 2021 Nov 06; doi: 10.1016/j.jclinepi.2021.10.027. Epub 2021 Nov 06.

OBJECTIVES: To assess whether drug regulatory agencies decided on applications for extended-release methylphenidate for use in adult ADHD based on select samples of trials.STUDY DESIGN AND SETTING: Case series of publicly available regulatory documents. We matched an index of...

Cite
Boesen K, Jørgensen KJ, Gøtzsche PC. Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents. J Clin Epidemiol. 2021;doi: 10.1016/j.jclinepi.2021.10.027.
Boesen, K., Jørgensen, K. J., & Gøtzsche, P. C. (2021). Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents. Journal of clinical epidemiology, . https://doi.org/10.1016/j.jclinepi.2021.10.027
Boesen, Kim, et al. "Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents." Journal of clinical epidemiology vol. (2021). doi: https://doi.org/10.1016/j.jclinepi.2021.10.027
Boesen K, Jørgensen KJ, Gøtzsche PC. Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents. J Clin Epidemiol. 2021 Nov 06; doi: 10.1016/j.jclinepi.2021.10.027. Epub 2021 Nov 06. PMID: 34752938.
Copy Download .nbib Format: NLM
Development of an aerogenous Escherichia coli infection model in adult broiler breeders.

Scientific reports

Kromann S, Olsen RH, Bojesen AM, Jensen HE, Thøfner I.
PMID: 34599201
Sci Rep. 2021 Oct 01;11(1):19556. doi: 10.1038/s41598-021-98270-8.

Escherichia coli constitutes an immense challenge to the poultry industry due to its devastating effect on productivity, mortality, and carcass condemnations. To aid future studies on disease mechanisms and interventions, an aerogenous infection model was established in adult broiler...

Cite
Kromann S, Olsen RH, Bojesen AM, et al. Development of an aerogenous Escherichia coli infection model in adult broiler breeders. Sci Rep. 2021;11(1):19556doi: 10.1038/s41598-021-98270-8.
Kromann, S., Olsen, R. H., Bojesen, A. M., Jensen, H. E., & Thøfner, I. (2021). Development of an aerogenous Escherichia coli infection model in adult broiler breeders. Scientific reports, 11(1), 19556. https://doi.org/10.1038/s41598-021-98270-8
Kromann, Sofie, et al. "Development of an aerogenous Escherichia coli infection model in adult broiler breeders." Scientific reports vol. 11,1 (2021): 19556. doi: https://doi.org/10.1038/s41598-021-98270-8
Kromann S, Olsen RH, Bojesen AM, Jensen HE, Thøfner I. Development of an aerogenous Escherichia coli infection model in adult broiler breeders. Sci Rep. 2021 Oct 01;11(1):19556. doi: 10.1038/s41598-021-98270-8. PMID: 34599201; PMCID: PMC8486767.
Copy Download .nbib Format: NLM
Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

Schizophrenia bulletin

Soldatos RF, Cearns M, Nielsen MØ, Kollias C, Xenaki LA, Stefanatou P, Ralli I, Dimitrakopoulos S, Hatzimanolis A, Kosteletos I, Vlachos II, Selakovic M, Foteli S, Nianiakas N, Mantonakis L, Triantafyllou TF, Ntigridaki A, Ermiliou V, Voulgaraki M, Psarra E, Sørensen ME, Bojesen KB, Tangmose K, Sigvard AM, Ambrosen KS, Meritt T, Syeda W, Glenthøj BY, Koutsouleris N, Pantelis C, Ebdrup BH, Stefanis N.
PMID: 34535800
Schizophr Bull. 2021 Sep 18; doi: 10.1093/schbul/sbab107. Epub 2021 Sep 18.

BACKGROUND: Validated clinical prediction models of short-term remission in psychosis are lacking. Our aim was to develop a clinical prediction model aimed at predicting 4-6-week remission following a first episode of psychosis.METHOD: Baseline clinical data from the Athens First...

Cite
Soldatos RF, Cearns M, Nielsen MØ, et al. Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning. Schizophr Bull. 2021;doi: 10.1093/schbul/sbab107.
Soldatos, R. F., Cearns, M., Nielsen, M. �. �., Kollias, C., Xenaki, L. A., Stefanatou, P., Ralli, I., Dimitrakopoulos, S., Hatzimanolis, A., Kosteletos, I., Vlachos, I. I., Selakovic, M., Foteli, S., Nianiakas, N., Mantonakis, L., Triantafyllou, T. F., Ntigridaki, A., Ermiliou, V., Voulgaraki, M., Psarra, E., Sørensen, M. E., Bojesen, K. B., Tangmose, K., Sigvard, A. M., Ambrosen, K. S., Meritt, T., Syeda, W., Glenthøj, B. Y., Koutsouleris, N., Pantelis, C., Ebdrup, B. H., & Stefanis, N. (2021). Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning. Schizophrenia bulletin, . https://doi.org/10.1093/schbul/sbab107
Soldatos, Rigas F, et al. "Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning." Schizophrenia bulletin vol. (2021). doi: https://doi.org/10.1093/schbul/sbab107
Soldatos RF, Cearns M, Nielsen MØ, Kollias C, Xenaki LA, Stefanatou P, Ralli I, Dimitrakopoulos S, Hatzimanolis A, Kosteletos I, Vlachos II, Selakovic M, Foteli S, Nianiakas N, Mantonakis L, Triantafyllou TF, Ntigridaki A, Ermiliou V, Voulgaraki M, Psarra E, Sørensen ME, Bojesen KB, Tangmose K, Sigvard AM, Ambrosen KS, Meritt T, Syeda W, Glenthøj BY, Koutsouleris N, Pantelis C, Ebdrup BH, Stefanis N. Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning. Schizophr Bull. 2021 Sep 18; doi: 10.1093/schbul/sbab107. Epub 2021 Sep 18. PMID: 34535800.
Copy Download .nbib Format: NLM
Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.

mBio

Zhu Z, Antenucci F, Villumsen KR, Bojesen AM.
PMID: 34372691
mBio. 2021 Aug 31;12(4):e0170721. doi: 10.1128/mBio.01707-21. Epub 2021 Aug 10.

Gram-negative bacteria include a number of pathogens that cause disease in humans and animals. Although antibiotics are still effective in treating a considerable range of infections caused by Gram-negative bacteria, the alarming increase of antimicrobial resistance (AMR) induced by...

Cite
Zhu Z, Antenucci F, Villumsen KR, et al. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. mBio. 2021;12(4):e0170721doi: 10.1128/mBio.01707-21.
Zhu, Z., Antenucci, F., Villumsen, K. R., & Bojesen, A. M. (2021). Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. mBio, 12(4), e0170721. https://doi.org/10.1128/mBio.01707-21
Zhu, Zhuang, et al. "Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance." mBio vol. 12,4 (2021): e0170721. doi: https://doi.org/10.1128/mBio.01707-21
Zhu Z, Antenucci F, Villumsen KR, Bojesen AM. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. mBio. 2021 Aug 31;12(4):e0170721. doi: 10.1128/mBio.01707-21. Epub 2021 Aug 10. PMID: 34372691; PMCID: PMC8406158.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 167 entries